SCHEMBL31078

SCHEMBL31078

COc1cccc(C(=O)c2nc3ccccc3s2)c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.65
MEN1 O00255 3/20 0.65
KMT2A Q03164 3/20 0.65
NPC1 O15118 2/20 0.65
DHODH Q02127 1/20 0.65
FAAH O00519 1/20 0.61
MAPT P10636 3/20 0.58
TP53 P04637 1/20 0.58
CNR2 P34972 1/20 0.57
KDM4E B2RXH2 1/20 0.57
LMNA P02545 1/20 0.57
GLO1 Q04760 1/20 0.57
HSD17B1 P14061 3/20 0.56
HSD17B2 P37059 3/20 0.56
ALDH1A1 P00352 2/20 0.56
SMN1; SMN2 Q16637 3/20 0.55
UBE2M P61081 1/20 0.55
DCUN1D1 Q96GG9 1/20 0.55
NFKB1 P19838 2/20 0.55
NFKB2 Q00653 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8401031 0.86 HSD17B1 (0.74) RAB9AMEN1KMT2ANPC1MAPT
SCHEMBL11007700 0.85 KMT2A (0.66) RAB9AMEN1KMT2ANPC1MAPT
SCHEMBL900311 0.84 MAPT (0.56) RAB9AMEN1KMT2ANPC1DHODH
SCHEMBL900711 0.82 SCD (0.62) RAB9AMEN1KMT2ANPC1FAAH
SCHEMBL8405370 0.81 HSD17B1 (0.74) RAB9AMEN1KMT2ANPC1MAPT
SCHEMBL31407 0.81 HSD17B1 (0.79) RAB9AFAAHTP53LMNAHSD17B1
SCHEMBL24751 0.80 HSD17B1 (0.62) RAB9AMEN1KMT2ANPC1MAPT
SCHEMBL27623260 0.79 HSD17B1 (0.67) RAB9AMEN1KMT2ANPC1FAAH
SCHEMBL427929 0.79 TUBB4A (0.72) RAB9AMEN1KMT2AFAAHMAPT
SCHEMBL4916511 0.79 NPC1 (1.00) RAB9AMEN1KMT2ANPC1DHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012025638-A1 SELECTIVE 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITORS Universität des Saarlandes (DE) 2012-03-01 WO disclosed